Anaïs Proust

Title: Anaïs Proust: Innovator in Antiviral Compositions

Introduction

Anaïs Proust is a notable inventor based in Lyons, France. He has made significant contributions to the field of antiviral research, particularly in the context of coronaviruses. His innovative work has led to the development of a unique pharmaceutical composition aimed at treating infections linked to coronaviruses.

Latest Patents

Anaïs Proust holds 1 patent for his invention titled "Antiviral compositions for the treatment of infections linked to coronaviruses." This invention focuses on a pharmaceutical or veterinary composition designed to prevent and/or treat MERS-CoV (Middle-East Respiratory Syndrome) coronavirus infections. The composition is characterized by its inclusion of at least one compound chosen from apigenin and berberine, all within a suitable pharmaceutical vehicle.

Career Highlights

Throughout his career, Anaïs Proust has been associated with prestigious institutions such as Université Claude Bernard Lyon 1 and Institut National de la Santé et de la Recherche Médicale. His work in these organizations has been pivotal in advancing research in antiviral therapies.

Collaborations

Anaïs has collaborated with esteemed colleagues, including Manuel Rosa-Calatrava and Olivier Terrier. These partnerships have enriched his research and contributed to the development of effective antiviral solutions.

Conclusion

Anaïs Proust's innovative contributions to antiviral compositions highlight his commitment to addressing critical health challenges. His work exemplifies the importance of research in combating viral infections and improving public health outcomes.